Anti-Programmed Death 1 (PD-1) Antibodies and the Pancreas: A Diabetic Storm Ahead?

Teresa Rodriguez-Calvo, Olov Ekwall, Natalie Amirian, Jose Zapardiel-Gonzalo, Matthias G. von Herrath, Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes Diabetes. ,vol. 63, pp. 3880- 3890 ,(2014) , 10.2337/DB14-0549

Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, Scott N. Gettinger, David C. Smith, David F. McDermott, John D. Powderly, Richard D. Carvajal, Jeffrey A. Sosman, Michael B. Atkins, Philip D. Leming, David R. Spigel, Scott J. Antonia, Leora Horn, Charles G. Drake, Drew M. Pardoll, Lieping Chen, William H. Sharfman, Robert A. Anders, Janis M. Taube, Tracee L. McMiller, Haiying Xu, Alan J. Korman, Maria Jure-Kunkel, Shruti Agrawal, Daniel McDonald, Georgia D. Kollia, Ashok Gupta, Jon M. Wigginton, Mario Sznol, Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. The New England Journal of Medicine. ,vol. 366, pp. 2443- 2454 ,(2012) , 10.1056/NEJMOA1200690

P. A. Gottlieb, K. C. Herold, J. M. Lachin, P. McGee, J. P. Palmer, M. D. Pescovitz, H. Krause-Steinrauf, J. S. Skyler, J. M. Sosenko, , C. J. Greenbaum, C. A. Beam, D. Boulware, S. E. Gitelman, Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data Diabetes. ,vol. 61, pp. 2066- 2073 ,(2012) , 10.2337/DB11-1538

Marie-Léa Gauci, Pauline Laly, Tiphaine Vidal-Trecan, Barouyr Baroudjian, Jérémy Gottlieb, Nika Madjlessi-Ezra, Laetitia Da Meda, Isabelle Madelaine-Chambrin, Martine Bagot, Nicole Basset-Seguin, Cécile Pages, Samia Mourah, Philippe Boudou, Céleste Lebbé, Jean-François Gautier, Autoimmune diabetes induced by PD-1 inhibitor-retrospective analysis and pathogenesis: a case report and literature review. Cancer Immunology, Immunotherapy. ,vol. 66, pp. 1399- 1410 ,(2017) , 10.1007/S00262-017-2033-8

Romualdo Barroso-Sousa, William T. Barry, Ana C. Garrido-Castro, F. Stephen Hodi, Le Min, Ian E. Krop, Sara M. Tolaney, Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis JAMA Oncology. ,vol. 4, pp. 173- 182 ,(2017) , 10.1001/JAMAONCOL.2017.3064

Lucien Marchand, Valérie Paulus, Nicole Fabien, Maurice Pérol, Charles Thivolet, Julien Vouillarmet, Pierre Saintigny, Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response. Journal of Thoracic Oncology. ,vol. 12, ,(2017) , 10.1016/J.JTHO.2017.07.021